Literature DB >> 10519431

Leptin concentrations in maternal serum and cord blood: relationship to maternal anthropometry and fetal growth.

M Geary1, P J Pringle, M Persaud, J Wilshin, P C Hindmarsh, C H Rodeck, C G Brook.   

Abstract

OBJECTIVE: To determine 1. the relationship between maternal serum leptin concentrations and maternal anthropometry and 2. the relationship between cord serum leptin concentrations at birth and neonatal anthropometry.
DESIGN: Prospective cohort study of fetal growth in low-risk pregnancies.
SETTING: University teaching hospital. SAMPLE: Thirty-nine women and their babies taking part in a fetal growth study.
METHODS: Blood was taken from the women between 10-20 weeks of gestation and from the umbilical cord of their babies at delivery. Serum leptin was measured by radio-immunoassay. Maternal anthropometric measurements were recorded at booking. Neonatal anthropometric measurements were recorded within 48 hours after delivery. Linear regression analysis was used to explore the relationship between serum leptin concentrations and anthropometric measures and multiple regression analysis then applied to determine which variables remained independently associated with leptin.
RESULTS: The median (range) leptin concentration in maternal serum was 11.8 ng/mL (1.7-39.7) and in cord blood was 4.2 ng/mL (0.6-21.4). Maternal leptin levels correlated with maternal weight, body mass index, midarm circumference and skinfold thickness, but not with birthweight, placental weight or maternal height. Body mass index and midarm circumference remained significant after multiple regression analysis. Cord leptin levels correlated with birthweight, birthlength, placental weight and skinfold thickness but not with ponderal index. Birthweight and subscapular skinfold thickness remained significant after multiple regression analysis. Cord leptin concentrations did not correlate with maternal leptin concentrations.
CONCLUSIONS: We suggest that there are very strong associations between maternal leptin and maternal adiposity in pregnancy, and between cord leptin at delivery and birthweight, as well as other anthropometric markers of fetal growth.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10519431     DOI: 10.1111/j.1471-0528.1999.tb08113.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  13 in total

Review 1.  Adult sequelae of intrauterine growth restriction.

Authors:  Michael G Ross; Marie H Beall
Journal:  Semin Perinatol       Date:  2008-06       Impact factor: 3.300

2.  Hypothalamic neurosphere progenitor cells in low birth-weight rat newborns: neurotrophic effects of leptin and insulin.

Authors:  Mina Desai; Tie Li; Michael G Ross
Journal:  Brain Res       Date:  2011-01-06       Impact factor: 3.252

3.  High Maternal and Low Cord Blood Leptin Are Associated with BMI-SDS Gain in the First Year of Life.

Authors:  Anna Telschow; Nina Ferrari; Clara Deibert; Anne Flöck; Waltraut M Merz; Ulrich Gembruch; Christina Ehrhardt; Jörg Dötsch; Christine Graf
Journal:  Obes Facts       Date:  2019-10-08       Impact factor: 3.942

4.  Association between maternal urinary arsenic species and infant cord blood leptin levels in a New Hampshire Pregnancy Cohort.

Authors:  Anala Gossai; Corina Lesseur; Shohreh Farzan; Carmen Marsit; Margaret R Karagas; Diane Gilbert-Diamond
Journal:  Environ Res       Date:  2014-11-20       Impact factor: 6.498

5.  Maternal pre-pregnancy BMI downregulates neonatal cord blood LEP methylation.

Authors:  R Kadakia; Y Zheng; Z Zhang; W Zhang; L Hou; J L Josefson
Journal:  Pediatr Obes       Date:  2016-12-08       Impact factor: 4.000

6.  Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood.

Authors:  Henar Ortega-Senovilla; Ute Schaefer-Graf; Katrin Meitzner; Michael Abou-Dakn; Kristof Graf; Ulrich Kintscher; Emilio Herrera
Journal:  Diabetes Care       Date:  2011-07-20       Impact factor: 19.112

7.  Mild gestational diabetes in pregnancy and the adipoinsular axis in babies born to mothers in the ACHOIS randomised controlled trial.

Authors:  Louise K Pirc; Julie A Owens; Caroline A Crowther; Kristyn Willson; Miles J De Blasio; Jeffrey S Robinson
Journal:  BMC Pediatr       Date:  2007-04-12       Impact factor: 2.125

8.  Exploring the Relationship Between Maternal Circulating Hormones and Gestational Weight Gain in Women Without Obesity: A Cross-Sectional Study.

Authors:  Martha Lappas; Ratana Lim; Sarah Price; Luke A Prendergast; Joseph Proietto; Elif I Ekinci; Priya Sumithran
Journal:  Int J Womens Health       Date:  2020-06-15

9.  Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the metformin in gestational diabetes (MiG) trial: responses to maternal metformin versus insulin treatment.

Authors:  Helen L Barrett; Kathryn L Gatford; Candice M Houda; Miles J De Blasio; H David McIntyre; Leonie K Callaway; Marloes Dekker Nitert; Suzette Coat; Julie A Owens; William M Hague; Janet A Rowan
Journal:  Diabetes Care       Date:  2012-10-09       Impact factor: 19.112

10.  Cord blood leptin and insulin levels in association with mitochondrial DNA content.

Authors:  Annette Vriens; Michelle Plusquin; Willy Baeyens; Liesbeth Bruckers; Elly Den Hond; Ilse Loots; Vera Nelen; Greet Schoeters; Bram G Janssen; Tim S Nawrot
Journal:  J Transl Med       Date:  2018-08-13       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.